9,10-dimethyl-1,2-benzanthracene has been researched along with acrylamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, YM; Hasumura, M; Hirose, M; Imai, T | 1 |
| Hippo, Y; Imai, T; Maru, Y; Masui, R; Naruse, M; Ochiai, M | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and acrylamide
| Article | Year |
|---|---|
Enhancement by acrylamide of N-methyl-N-nitrosourea-induced rat mammary tumor development-possible application for a model to detect co-modifiers of carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acrylamide; Administration, Oral; Alkylating Agents; Animals; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Interactions; Female; Mammary Neoplasms, Animal; Methylnitrosourea; Nitrosamines; Rats; Rats, Sprague-Dawley; Thyroid Neoplasms | 2005 |
An organoid-based carcinogenesis model induced by in vitro chemical treatment.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acrylamide; Animals; Carcinogenesis; Carcinogens; Diethylnitrosamine; Ethyl Methanesulfonate; Liver; Lung; Mice; Mice, Knockout; Mice, Nude; Neoplasms, Experimental; Organoids; Tumor Suppressor Protein p53 | 2020 |